Exhibit 99.1
|
| Axcan Pharma inc. |
VIA SEDAR
February 11, 2008
TO : |
| Autorités Des Marchés Financiers |
|
| British Columbia Securities Commission |
|
| Alberta Securities Commission |
|
| Manitoba Securities Commission |
|
| Ontario Securities Commission |
|
| Saskatchewan Securities Commission |
|
| New Brunswick Securities Commission |
|
| Nova Scotia Securities Commission |
|
| Registrar of Securities, P.E.I. |
|
| Government of Newfoundland & Labrador |
|
|
|
RE : |
| Axcan Pharma Inc. |
|
|
|
|
| Report on Voting Results pursuant to Section 11.3 of National Instrument 51-102 - ontinous Disclosure Obligations |
Sirs,
We hereby advise you of the following results obtained at the Annual and Special meeting of shareholders of Axcan Pharma Inc. (the “Corporation”) held on January 25, 2008:
ITEM VOTED UPON | VOTING RESULT | |
Special resolution contemplating the acquisition of all outstanding shares of Axcan Pharma Inc. |
| The vote on a special resolution in the form annexed as “Appendix A” to the Management Information Circular of Axcan Pharma Inc. (“Axcan”) dated December 21, 2007, to approve the Plan of Arrangement under section 192 of the Canada Business Corporations Act involving Axcan, its common shareholders and 4445660 Canada Inc. (the “Purchaser”), an affiliate of TPG Partners V, L.P., contemplating the acquisition by the Purchaser of all outstanding common shares of Axcan was approved on a vote by show of hands. |
Yours truly,
Signed at Mont-Saint-Hilaire, Quebec, on February 11, 2008
François Painchaud
Corporate Secretary
Axcan Pharma Inc.